Eton Pharmaceuticals

ETON

Current ValuationThe current P/E ratio is 112.64, above the reasonable range, cheaper than 6.14% of the time in the past 3 years, and the industry ranks 56/256, the industry Median -1.11.

112.64xP/E
Stock price$50.00Earnings per share$0.44

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
MRKUSMerck
112.95x81.16%$358.41B
CORTUSCorcept Therap
171.02x148.29%$9.28B
HCMUSHutchmed China
140.10x90.18%$2.51B
ETONUSEton Pharmaceuticals
112.64x739.71%$1.43B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.